Lv6
2310 积分 2025-08-07 加入
JBI-802: the first orally available LSD1/HDAC6 dual inhibitor to enter clinical trials
12小时前
已完结
Spirocyclic compounds as innovative tools in drug discovery for medicinal chemists
10天前
已完结
Efficient and rapid electrocatalytic degradation of polyethylene glycol by ammonium jarosite
17天前
已完结
Novel Dual Inhibitor of LSD1-HDAC6/8 for Treatment of Cancer
23天前
已完结
Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
23天前
已完结
Discovery of Novel 5-Cyano-3-phenylindole-Based LSD1/HDAC Dual Inhibitors for Colorectal Cancer Treatment
23天前
已完结
Preclinical Evaluation of INCB160058 - a Novel and Potentially Disease-Modifying Therapy for JAK2V617F Mutant Myeloproliferative Neoplasms
30天前
已完结
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study
1个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
1个月前
已完结
Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs)
1个月前
已完结
皖公网安备34019202002308
